Bombesin-like receptor 3
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
| Bombesin-like receptor 3
| ||||||||||||||
| Identifiers | ||||||||||||||
| Symbol(s) | BRS3; | |||||||||||||
| External IDs | OMIM: 300107 MGI: 1100501 Homologene: 1307 | |||||||||||||
| ||||||||||||||
| RNA expression pattern | ||||||||||||||
| Orthologs | ||||||||||||||
| Human | Mouse | |||||||||||||
| Entrez | 680 | 12209 | ||||||||||||
| Ensembl | ENSG00000102239 | ENSMUSG00000031130 | ||||||||||||
| Uniprot | P32247 | O54798 | ||||||||||||
| Refseq | NM_001727 (mRNA) NP_001718 (protein) | NM_009766 (mRNA) NP_033896 (protein) | ||||||||||||
| Location | Chr X: 135.4 - 135.4 Mb | Chr X: 53.39 - 53.4 Mb | ||||||||||||
| Pubmed search | [1] | [2] | ||||||||||||
The bombesin-like receptor 3 (BRS-3) is a G protein-coupled receptor.[1] As no endogenous ligand has been identified for BRS-3, it is classified as an orphan receptor.
Mammalian bombesin-like peptides (see MIM 137260) are widely distributed in the central nervous system as well as in the gastrointestinal tract, where they modulate smooth-muscle contraction, exocrine and endocrine processes, metabolism, and behavior. They bind to G protein-coupled receptors on the cell surface to elicit their effects. Bombesin-like peptide receptors include gastrin-releasing peptide receptor (MIM 305670), neuromedin B receptor (MIM 162341), and bombesin-like receptor-3 (BRS3) (Ohki-Hamazaki et al., 1997).[supplied by OMIM][1]
References
Further reading
- Gorbulev V, Akhundova A, Grzeschik KH, Fahrenholz F (1994). "Organization and chromosomal localization of the gene for the human bombesin receptor subtype expressed in pregnant uterus.". FEBS Lett. 340 (3): 260-4. PMID 8131855.
- Fathi Z, Corjay MH, Shapira H, et al. (1993). "BRS-3: a novel bombesin receptor subtype selectively expressed in testis and lung carcinoma cells.". J. Biol. Chem. 268 (8): 5979-84. PMID 8383682.
- Kane MA, Toi-Scott M, Johnson GL, et al. (1996). "Bombesin-like peptide receptors in human bronchial epithelial cells.". Peptides 17 (1): 111-8. PMID 8822519.
- Ohki-Hamazaki H, Watase K, Yamamoto K, et al. (1997). "Mice lacking bombesin receptor subtype-3 develop metabolic defects and obesity.". Nature 390 (6656): 165-9. doi:10.1038/36568. PMID 9367152.
- Ryan RR, Weber HC, Hou W, et al. (1998). "Ability of various bombesin receptor agonists and antagonists to alter intracellular signaling of the human orphan receptor BRS-3.". J. Biol. Chem. 273 (22): 13613-24. PMID 9593699.
- Liu J, Lao ZJ, Zhang J, et al. (2002). "Molecular basis of the pharmacological difference between rat and human bombesin receptor subtype-3 (BRS-3).". Biochemistry 41 (28): 8954-60. PMID 12102638.
- Ross MT, Grafham DV, Coffey AJ, et al. (2005). "The DNA sequence of the human X chromosome.". Nature 434 (7031): 325-37. doi:10.1038/nature03440. PMID 15772651.
- Hou X, Wei L, Harada A, Tatamoto K (2007). "Activation of bombesin receptor subtype-3 stimulates adhesion of lung cancer cells.". Lung Cancer 54 (2): 143-8. doi:10.1016/j.lungcan.2006.08.005. PMID 16979789.
- Tan YR, Qin XQ, Xiang Y, et al. (2007). "PPARalpha and AP-2alpha regulate bombesin receptor subtype 3 expression in ozone-stressed bronchial epithelial cells.". Biochem. J. 405 (1): 131-7. doi:10.1042/BJ20061754. PMID 17355223.
External links
This article incorporates text from the United States National Library of Medicine, which is in the public domain.
Template:Membrane-protein-stub
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

